Suppr超能文献

相似文献

1
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1988 Jan;32(1):96-103. doi: 10.1128/AAC.32.1.96.
3
Pneumocystis carinii pneumonia: therapy and prophylaxis.
J Infect Dis. 1988 Jul;158(1):254-9. doi: 10.1093/infdis/158.1.254.
4
Prevention of Pneumocystis carinii pneumonia.
Med Lett Drugs Ther. 1988 Oct 7;30(776):94-5.
7
Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1988 May;32(5):623-5. doi: 10.1128/AAC.32.5.623.
8
Pneumocystis carinii pneumonia in the patient with AIDS.
Chest. 1985 Nov;88(5):758-62. doi: 10.1378/chest.88.5.758.
10
Prophylaxis and treatment of Pneumocystis carinii pneumonia.
Br J Hosp Med. 1991 May;45(5):277-8, 280, 283.

引用本文的文献

1
Anti-Toxoplasma gondii effect of tylosin in vitro and in vivo.
Parasit Vectors. 2024 Feb 10;17(1):59. doi: 10.1186/s13071-024-06157-0.
3
Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.
J Fungi (Basel). 2022 Jan 27;8(2):129. doi: 10.3390/jof8020129.
5
Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.
Antimicrob Agents Chemother. 2002 Sep;46(9):3101-3. doi: 10.1128/AAC.46.9.3101-3103.2002.
6
Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase.
Antimicrob Agents Chemother. 2000 Nov;44(11):3092-6. doi: 10.1128/AAC.44.11.3092-3096.2000.
7
Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
Thorax. 2000 Aug;55 Suppl 1(Suppl 1):S15-22. doi: 10.1136/thorax.55.suppl_1.s15.
8
Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.
Antimicrob Agents Chemother. 1997 Feb;41(2):251-8. doi: 10.1128/AAC.41.2.251.
10
Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1996 Apr;40(4):962-5. doi: 10.1128/AAC.40.4.962.

本文引用的文献

1
Effects of bacterial pneumonitis on development of pneumocystosis in rats.
Am Rev Respir Dis. 1982 Jun;125(6):723-6. doi: 10.1164/arrd.1982.125.6.723.
2
Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia.
Ann Intern Med. 1980 Jun;92(6):762-9. doi: 10.7326/0003-4819-92-6-762.
3
Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.
Infect Immun. 1980 Mar;27(3):928-37. doi: 10.1128/iai.27.3.928-937.1980.
4
Growth and serial passage of Pneumocystis carinii in the A549 cell line.
Infect Immun. 1984 May;44(2):245-51. doi: 10.1128/iai.44.2.245-251.1984.
6
Assessment of therapy for pneumocystis carinii pneumonia. PCP Therapy Project Group.
Am J Med. 1984 Mar;76(3):501-8. doi: 10.1016/0002-9343(84)90670-3.
7
Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis.
Antimicrob Agents Chemother. 1984 Oct;26(4):436-40. doi: 10.1128/AAC.26.4.436.
9
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.
Ann Intern Med. 1984 Apr;100(4):495-9. doi: 10.7326/0003-4819-100-4-495.
10
Pneumocystis carinii pneumonia treated with pyrimethamine and sulfadiazine.
Ann Intern Med. 1971 Oct;75(4):505-9. doi: 10.7326/0003-4819-75-4-505.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验